ANI Pharmaceuticals, Inc. (ANIP)
71.47
+0.41
(+0.58%)
USD |
NASDAQ |
Nov 13, 16:00
71.47
0.00 (0.00%)
After-Hours: 19:59
ANI Pharmaceuticals Price to Book Value : 2.569 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.554 |
| November 11, 2026 | 2.555 |
| November 10, 2026 | 2.561 |
| November 09, 2026 | 2.437 |
| November 06, 2026 | 2.423 |
| November 05, 2026 | 2.502 |
| November 04, 2026 | 2.576 |
| November 03, 2026 | 2.598 |
| November 02, 2026 | 2.540 |
| October 30, 2026 | 2.588 |
| October 29, 2026 | 2.630 |
| October 28, 2026 | 2.578 |
| October 27, 2026 | 2.558 |
| October 26, 2026 | 2.610 |
| October 23, 2026 | 2.61 |
| October 22, 2026 | 2.651 |
| October 21, 2026 | 2.597 |
| October 20, 2026 | 2.612 |
| October 19, 2026 | 2.608 |
| October 16, 2026 | 2.598 |
| October 15, 2026 | 2.598 |
| October 14, 2026 | 2.522 |
| October 13, 2026 | 2.546 |
| October 12, 2026 | 2.645 |
| October 09, 2026 | 2.656 |
| Date | Value |
|---|---|
| October 08, 2026 | 2.587 |
| October 07, 2026 | 2.586 |
| October 06, 2026 | 2.571 |
| October 05, 2026 | 2.609 |
| October 02, 2026 | 2.594 |
| October 01, 2026 | 2.623 |
| September 30, 2026 | 2.611 |
| September 29, 2026 | 2.793 |
| September 28, 2026 | 2.878 |
| September 25, 2026 | 2.846 |
| September 24, 2026 | 2.848 |
| September 23, 2026 | 2.863 |
| September 22, 2026 | 2.997 |
| September 21, 2026 | 3.033 |
| September 18, 2026 | 2.929 |
| September 17, 2026 | 2.900 |
| September 16, 2026 | 2.831 |
| September 15, 2026 | 2.774 |
| September 14, 2026 | 2.708 |
| September 11, 2026 | 2.700 |
| September 10, 2026 | 2.749 |
| September 09, 2026 | 2.720 |
| September 08, 2026 | 2.702 |
| September 04, 2026 | 2.740 |
| September 03, 2026 | 2.769 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 33.76 |
| Supernus Pharmaceuticals, Inc. | 1.628 |
| Ocular Therapeutix, Inc. | 3.094 |
| Corcept Therapeutics, Inc. | 9.570 |
| Veru, Inc. | 1.274 |
Price to Book Value Related Metrics
| PE Ratio | 14.27 |
| PS Ratio | 1.491 |
| PEG Ratio | 0.0689 |
| Price to Free Cash Flow | 7.767 |
| Price | 71.47 |
| Earnings Yield | 7.01% |
| Market Cap | 1.637B |
| PEGY Ratio | 0.0689 |
| Operating PE Ratio | 9.735 |
| Normalized PE Ratio | 15.66 |